Results 91 to 100 of about 787 (175)

Issue Information

JEADV Clinical Practice, Volume 5, Issue 1, Page 1-6, March 2026.
wiley   +1 more source

New Therapies in the Biological Treatment of Psoriasis: A Review

Allergies
Psoriasis is a chronic inflammatory autoimmune disease primarily affecting the skin and, in some cases, the joints, and is characterized by erythematous, scaling lesions. Building up the doses has been conventional, but many patients will not obtain good
Mateusz Kamil Ożóg, Alicja Derkacz, Dawid Klimczak, Sara Winkler, Laura Wojciuch   +4 more
doaj   +1 more source

Correction to: Spesolimab: First Approval

Drugs, 2022
openaire   +1 more source

Case report: A rollercoaster journey of pemphigus vegetans

Frontiers in Immunology
Pemphigus vegetans (P Veg), the rarest subtype of pemphigus, is characterized by vegetative plaques, primarily affecting intertriginous areas. The most common autoantibodies target desmoglein 3 (Dsg3).
Xiaoyuan Hou, Jia Chen
doaj   +1 more source

Generalised pustular psoriasis triggered by monkeypox vaccination successfully treated with spesolimab

Generalised pustular psoriasis (GPP) is characterised by a widespread rash with pustules and fever. Clinical and the histological overlap with the delayed hypersensitivity reaction acute generalised exanthematous pustulosis may delay the diagnostics and ...
Assia V. Bassarova, Astrid H. Lossius, Kim M. A. S. Endre, Olav Sundnes, Jose H. Alfonso   +4 more
core   +1 more source

Exploring the Chronic Nature of Generalized Pustular Psoriasis [Podcast]

Clinical, Cosmetic and Investigational Dermatology
Boni Elewski,1 Mark G Lebwohl2 1Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA; 2Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: Boni Elewski, Email belewski@uabmc.eduAbstract: Generalized ...
Elewski B, Lebwohl MG
doaj  

Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL® 2 study

Supplement material for "Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL® 2 study", published in the Journal of the American Academy of Dermatology (https://doi.org/10 ...
Eckhardt, Michael
core   +1 more source

Supplemental Material:A Case of Delayed-Onset Postoperative Pyoderma Gangrenosum Complicated with Chronic Myelomonocytic Leukemia Treated with Spesolimab

This dataset contains clinical data from a 63-year-old male patient who developed delayed-onset pyoderma gangrenosum (PG) following laparoscopic inguinal hernia repair and was subsequently diagnosed with chronic myelomonocytic leukemia (CMML).
Wang, Xue
core   +1 more source

Spesolimab for treating generalised pustular psoriasis flares: a single technology appraisal

This report is a critique of the company’s submission (CS) to NICE from BoehringerIngelheim Ltd on the clinical effectiveness and cost effectiveness of spesolimab (Spevigo) for treating adults with generalised pustular psoriasis presenting with flares ...
Picot, Jo, Ribeiro, Ines, Hawa, Asyl, Woods, Lois   +3 more
core   +1 more source

Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels

Journal of Inflammation Research
Yunliu Chen,1,2,* Zhaoyang Wang,1,2,* Yuan Liang,1,2 Chunping Shen,1,2 Lei Jiao,1,2 Xin Xiang,1,2 Chaoyang Miao,1,2 Zigang Xu1,2 1Department of Dermatology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s ...
Chen Y, Wang Z, Liang Y, Shen C, Jiao L, Xiang X, Miao C, Xu Z   +7 more
doaj